Commission Programme
Terms and Conditions

1. Scope

This Commission Programme applies to healthcare practitioners approved to refer Microba testing kits in the United Kingdom, in respect of Microba testing kits sold in the United Kingdom only. It does not extend to any other Microba region, product line, or practitioner arrangement.

2. Definitions

  • ‘Healthcare practitioner’ means a health-related professional who has been approved by Microba to participate in this Commission Programme and who meets the Practitioner Eligibility requirements below.
  • A ‘client’ is any end user of the products associated with Microba Pty Ltd and who has accessed our services through a registered healthcare practitioner.
  • Microba Pty Ltd reserves the right to refuse or remove clinicians from their active list of approved healthcare practitioners or clients from their database.
  • The Commission Programme is not available to any practitioner who currently holds registration with the General Medical Council (GMC), the Nursing and Midwifery Council (NMC), the General Pharmaceutical Council (GPhC), or the Health and Care Professions Council (HCPC) as a dietitian. This applies in all capacities, including where the practitioner also operates a private, functional or integrative clinic, and whether or not they are on the GP or Specialist Register.
  • RRP means recommended retail price and is the full price of an item, with no discounts included.
  • ‘Microba’, ‘we’, ‘us’ and ‘our’ means Microba Pty Ltd (ABN 30 628 603 225), the seller of Microba testing kits under this Commission Programme.
  • ‘Invivo’ means Invivo Clinical Ltd (company number 06187743), a member of the Microba Life Sciences group, which administers this Commission Programme on behalf of Microba, including issuing commission statements, receiving practitioner invoices and paying commission.

3. Practitioner Eligibility

3.1. Eligibility basis

Participation in the Commission Programme is limited to practitioners whose professional activities are compatible with the use of Microba testing services and who meet Microba’s onboarding requirements. Microba reserves the right to determine practitioner eligibility and may decline or withdraw participation where a practitioner’s regulatory status, professional obligations or scope of practice may create compliance risks.

3.2. Who can participate

To participate, a healthcare practitioner must:

(a) meet Microba’s practitioner onboarding requirements, as notified at onboarding;

(b) not hold registration with any regulator listed in the Definitions;

(c) have been approved by Microba following onboarding, including the declaration below; and

(d) recommend and use Microba testing kits only within their professional scope and competence.

3.3. Declaration and verification

When applying, a healthcare practitioner must declare whether they currently hold registration with any regulator listed in the Definitions. They must tell Microba within 14 days of any change. Microba may check registration status against the relevant public register at any time. A practitioner who gives inaccurate information, or who becomes ineligible, ceases to be eligible from that date. Microba may stop paying commission from that date and may recover commission paid for any period of ineligibility.

3.4. Disclosure to clients

Healthcare practitioners participating in this Commission Programme must clearly inform their clients where they may receive a commission in relation to the purchase of Microba testing kits. Disclosure must be made clearly and transparently before the client makes a purchase, so that the client understands the commercial relationship between the practitioner and Microba.

4. Information

The healthcare practitioner must ensure that the information we hold and that the patients linked to their accounts is up to date and accurate at all times.

The healthcare practitioner is responsible for informing their clients about pricing and commission.

5. Qualifying Purchases

Commissions will be payable to the healthcare practitioner on testing kits that have been purchased by their clients during the designated period. No commissions will be paid on other purchases such as educational materials.

Orders must have been received, despatched and paid for by the patient before the commission will be registered on the commission statement.

If any returns have been made by the patient and credited or refunded back to them, the value of the credit or refund will be deducted from the next qualifying commission statements.

Commissions will only be payable on purchases where the client has paid RRP and has not received any discounts or used any promotional coupons or codes.

Microba Pty Ltd reserves the right to alter or amend testing kits which qualify to be included in the commission calculations.

6. Clinical Independence

Healthcare practitioners must exercise independent professional judgement when recommending any Microba test, product or service. Participation in the Microba Commission Programme must not influence clinical decision-making or lead to tests being recommended where they are not clinically appropriate.

Microba expects healthcare practitioners to recommend testing solely based on the individual needs of the client and within their professional scope of practice.

7. Appropriate Use of Tests

Microba testing kits are in vitro diagnostic devices and must only be recommended and used in accordance with their intended use and product instructions.

Healthcare practitioners must ensure that the use of testing kits falls within their professional competence and scope of practice and that any interpretation of results is carried out responsibly and in accordance with applicable professional guidance.

8. Commission Rates

Rates paid will be dependent upon the product or service being purchased and Microba reserves the right to vary these from time to time.

9. Commission Statement and Invoicing

At the end of every calendar quarter, the healthcare practitioner will receive a commission statement from Invivo detailing the purchases made by their patients and the calculated amount of commission.

It is the healthcare practitioner’s responsibility to check the statement and ensure that any discrepancies are reported to the Customer Services team (info@invivohealthcare.com) within 14 days of the statement date.

The healthcare practitioner must send an invoice to Invivo Clinical for the commission amount, including VAT where applicable, within 30 days of the statement date to the Accounts team (accounts@invivohealthcare.com). Failure to send the invoice within 30 days means that the healthcare practitioner will forfeit their commission and it will not be payable.

Invoices should be sent, and will be settled in, GBP only.

Healthcare practitioners must ensure the invoice values are correct and correlate to the commission statement and that bank details for payment are included in the detail.

Invivo will endeavour to pay commission invoices within 30 days of the invoice date.

10. Data Protection

Microba will process any personal data provided under this Commission Programme, including bank account details and VAT information, in accordance with UK GDPR, the Data Protection Act 2018, and Microba's Privacy Policy.

Healthcare practitioners should refer to Microba's Privacy Policy for further information on how their personal data is collected, used and protected.

11. Changes to the Scheme

Microba Pty Ltd holds the right to change or amend the details of this scheme at any time.

12. Governing Law

This Commission Programme, and any dispute or claim arising out of or in connection with it, is governed by and construed in accordance with the laws of England and Wales, and the parties submit to the exclusive jurisdiction of the courts of England and Wales.

‍